Medical Information
India
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for India Healthcare Professionals. Would you like to proceed?

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Oral Presentation
Witteles R, Sultan MB, Gundapaneni B, Garcia-Pavia P September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Waddington Cruz M, Planté-Bordeneuve V, Inamo J, Kristen A, Chapman D, Glass O, Amass L September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Diemberger I, Lino Cirami C, Luigetti M, Dispenzieri A, Grogan M, Chapman D, Glass O, Amass L September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Luigetti M, DiPaolantonio A, Mazzeo A, Diemberger I, Chapman D, Glass O, Amass L September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Planté-Bordeneuve V, Dori A, Dispenzieri A, Grogan M, Adams D, Chapman D, Glass O, Amass L September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Grogan M, Sultan MB, Gundapaneni B, Crespo-Leiro MG September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Gonzalez Duarte A, Sultan M, Glass O, Chapman D, Amass L, Mazzeo A September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Rapezzi C, Sultan MB, Gundapaneni B, Schumacher J, Keohane D, Davis MK September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Poster
Koutitas G, Nolen K, Attal S September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)
Oral Presentation
Grogan M, Sultan MB, Gundapaneni B, Hanna M September 5, 2022 ISA 2022 Transthyretin Amyloidosis (ATTR)